2004
Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, Apstein CS, Liao R
Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circulation Res, 94: 1008-1010, 2004.
Connors LH, Yamashita T, Yazaki, Skinner M, Benson MD
A rare transthyretin mutation (Asp18Glu) associated with cardiomyopathy. Amyloid
J Protein Folding Disorders, 11: 61-66, 2004.
Sanchorawala V, Wright DW, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M (PDF)
High-dose intravenous melphalan and autologous stem sell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplantation, 33: 381-388, 2004.
Schlezinger, J. J., G. J. Howard, C. H. Hurst, J. K. Emberley, D. J. Waxman, T. Webster, and D. H. Sherr
Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-Delta12,14-prostaglandin J2. J Immunol. 173:3165, 2004.
Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Berk JL, Dember LM, Falk RH, Skinner M (PDF)
Improvement in quality of life of patients with AL amyloidosis treated with high dose melphalan and autologous stem cell transplantation. Blood, 104: 1888-1893, 2004.
Seldin DC
Interfering with Amyloidosis. Blood,104 3419-3420, 2004.
Sipe J and Seldin DC
Selected Highlights of the Xth International Symposium on Amyloid and Amyloidosis, Tours, France, April 18–22, 2004. Amyloid, J Protein Folding Disorders, 11:268-272, 2004.
Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O’Hara CJ, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG (PDF)
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis, an 8-year study. Annals Int Med, 140: 85-93, 2004.
Skinner M, Seldin DC
Amyloidosis, In Current Therapy in Allergy, Immunology and Rheumatology, 6th edition, Ed by LM Lichtenstein, WW Busse, RS Geha, Harcourt, Orlando, pp 260-267, 2004.
|
